Pharmaceutical Executive
December 01, 2012
Issue PDF
0
0
The Puzzle Master
December 01, 2012
Column
0
0
Tax and budget decisions will shape the healthcare market and drug research and regulation.
December 01, 2012
From the Editor
0
0
The calendar says its wrap-up time, not just for gifts but for some of the trends that shaped the industry-for good or bad-in 2012.
December 01, 2012
Features
0
0
At two years and counting, what's the secret of success in negotiating pricing under the new AMNOG legislation?
December 01, 2012
Features
0
0
Eli Lilly's pioneering pact with leading CRO Covance made big news when it happened. Four years later, both parties can point to metrics that suggest the benefit is mutual.
December 01, 2012
Features
0
0
Europe's chief regulator charts a strategy from many moving parts. Dr Guido Rasi talks to Pharm Exec's William Looney.
December 01, 2012
Column
0
0
Ben Comer profiles 10 innovative technologies designated as new and revolutionary tools for the treatment of disease and disability.